Vanguard Capital Management »

Senti Biosciences shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Senti Biosciences (SNTI) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Senti Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Senti Biosciences held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Senti Biosciences by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $437k 538k 0.81

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Capital Management

Top funds holding Senti Biosciences

NEA Management Company
Nantahala Capital Management
Vanguard Group
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
Virtu Financial
Menlo Ventures Management
BlackRock
Northern Trust
Hrt Financial
Goss Wealth Management
State Street Corporation
UBS Group
Tower Research Capital

View all funds holding Senti Biosciences